Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03456414
Other study ID # 2017/0638
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 11, 2018
Est. completion date September 30, 2018

Study information

Verified date July 2020
Source Cardenal Herrera University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of this investigation is to assess if an intradialysis virtual reality exercise-based program results in an improvement in physical function and if it results in high adherence rates to exercise. The secondary aim is to assess the effect of intradialysis VR in physical activity level, health related quality of life and in cognitive function.


Description:

Participants will be randomized into one of two groups. The first group will start with 12 weeks of virtual reality exercise during hemodialysis and will carry on with a control period of 12 weeks. The second group will start with a control period of 12 weeks (no exercise) and will carry on with a virtual reality exercise period of 12 weeks.

The virtual reality exercise will undertake up to 30 minutes of exercise. After warming up, participants will play to an adapted 'treasure hunt' game. Their legs movements will be the players projected into an individual tv that will give them feedback regarding their achievements. The aim of the game will be to achieve the higher possible score.They will move their legs to pick up coins and to avoid bombs. An adapted Kinect technology will be used for the game development. The exercise session will end-up with a cool-down period that will include simple lower limb stretching exercises.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date September 30, 2018
Est. primary completion date September 1, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- At least 3 months in hemodialysis treatment

- Clinically stable

Exclusion Criteria:

- Recent cardiac events (less than 3 months)

- Unable to exercise

Study Design


Intervention

Other:
Virtual reality exercise during hemodialysis
Subjects will play a virtual reality game specially adapted for subjects undertaking hemodialysis treatment

Locations

Country Name City State
Spain Hospital de Manises Manises Valencia

Sponsors (3)

Lead Sponsor Collaborator
Cardenal Herrera University Hospital de Manises, Universitat Politècnica de València

Country where clinical trial is conducted

Spain, 

References & Publications (6)

Segura-Ortí E, Gordon PL, Doyle JW, Johansen KL. Correlates of Physical Functioning and Performance Across the Spectrum of Kidney Function. Clin Nurs Res. 2018 Jun;27(5):579-596. doi: 10.1177/1054773816689282. Epub 2017 Jan 23. — View Citation

Segura-Orti E, Johansen KL. Exercise in end-stage renal disease. Semin Dial. 2010 Jul-Aug;23(4):422-30. doi: 10.1111/j.1525-139X.2010.00766.x. Review. — View Citation

Segura-Ortí E, Kouidi E, Lisón JF. Effect of resistance exercise during hemodialysis on physical function and quality of life: randomized controlled trial. Clin Nephrol. 2009 May;71(5):527-37. — View Citation

Segura-Ortí E, Martínez-Olmos FJ. Test-retest reliability and minimal detectable change scores for sit-to-stand-to-sit tests, the six-minute walk test, the one-leg heel-rise test, and handgrip strength in people undergoing hemodialysis. Phys Ther. 2011 Aug;91(8):1244-52. doi: 10.2522/ptj.20100141. Epub 2011 Jun 30. — View Citation

Segura-Ortí E, Rodilla-Alama V, Lisón JF. [Physiotherapy during hemodialysis: results of a progressive resistance-training programme]. Nefrologia. 2008;28(1):67-72. Spanish. — View Citation

Segura-Ortí E. [Exercise in haemodyalisis patients: a literature systematic review]. Nefrologia. 2010;30(2):236-46. doi: 10.3265/Nefrologia.pre2010.Jan.10229. Epub 2010 Jan 21. Review. Spanish. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline gait speed at 12 weeks Speed to cover 4 meters at normal speed Baseline, 12 weeks
Secondary Change from baseline sit to stand 10 at 12 weeks Time to perform 10 sit to stand repetitions, Baseline, 12 weeks
Secondary Change from baseline sit to stand 60 at 12 weeks Sit to stand repetitions performed in 60 seconds Baseline, 12 weeks
Secondary Change from baseline timed up and go at 12 weeks Time to stand up, walk 3 meters, come back and sit down again Baseline, 12 weeks
Secondary Change from baseline short physical performance battery at 12 weeks Score achieved at the battery that includes balance tests, sit to stand to sit 5 and and gait speed Baseline, 12 weeks
Secondary Change from baseline handgrip at 12 weeks Bilateral handgrip strength Baseline, 12 weeks
Secondary Change from baseline one-leg standing test at 12 weeks Time achieved while standing on one leg Baseline, 12 weeks
Secondary Change from baseline one-leg heel rise test at 12 weeks Number of heel rise repetitions achieved Baseline, 12 weeks
Secondary Change from baseline 6 minutes walk test at 12 weeks Number of meters walked in 6 minutes Baseline, 12 weeks
Secondary Change from baseline Physical activity level at 12 weeks Physical activity questionnaires Baseline, 12 weeks
Secondary Change from baseline Health related quality of life at 12 weeks Short Form 36 questionnaire to measure health-related quality of life Baseline, 12 weeks
Secondary Change from baseline Cognitive function at 12 weeks Mini-mental State Examination questionnaire Baseline, 12 weeks
Secondary Adherence Sessions performed/sessions offered 12 weeks
Secondary Healthcare resources expenditure and costs Total amount in euros spent on external consultations, laboratory tests, radiology tests, hospital pharmacy, emergency department healthcare provision, and hospitalisation. 12 months before starting the exercise program- 12 months after the starting date
See also
  Status Clinical Trial Phase
Completed NCT04076488 - Feasibility of an Interactive Tablet-based Exercise Program for People With Chronical Diseases N/A
Completed NCT03289650 - Extended Release Tacrolimus vs. Twice-Daily Tacrolimus Phase 3
Completed NCT04042324 - A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients Phase 1/Phase 2
Completed NCT01242904 - Use of a Bimodal Solution for Peritoneal Dialysis Phase 2
Active, not recruiting NCT03183245 - Comparison of the Human Acellular Vessel (HAV) With Fistulas as Conduits for Hemodialysis Phase 3
Completed NCT03257410 - Theranova 400 Dialyzer In End Stage Renal Disease (ESRD) Patients N/A
Completed NCT03627299 - Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors Phase 4
Recruiting NCT05917795 - Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates N/A
Terminated NCT03539861 - Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients N/A
Withdrawn NCT02130817 - Belatacept in Kidney Transplantation of Moderately Sensitized Patients Phase 4
Completed NCT05540457 - Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis) N/A
Not yet recruiting NCT04900610 - The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis N/A
Recruiting NCT02176434 - Pilot Feasibility Study of Combined Kidney and Hematopoietic Stem Cell Transplantation to Cure End-stage Renal Disease N/A
Active, not recruiting NCT02581449 - Effect of Omega-3 Fatty Acids on Oxidative Stress and Dyslipidemia in Pediatric Patients Undergoing Hemodialysis Phase 2
Completed NCT02830490 - Reliability of Functional Measures in Hemodialysis Patient. N/A
Completed NCT02832440 - Comparison of Two Exercise Programmes in Patients Undergoing Hemodialysis N/A
Completed NCT02215655 - Increasing Autonomous Motivation in ESRD to Enhance Phosphate Binder Adherence N/A
Completed NCT02832466 - Quantifying the Deterioration of Physical Function in Renal Patients N/A
Completed NCT02134314 - C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI Phase 1/Phase 2
Recruiting NCT01912001 - Virtual Ward for Home Dialysis N/A